“HRT - The Dilemma”
Many women in early 2002 who saw hormone replacement therapy (HRT) as their fountain of youth were shocked to learn that it not only failed to deliver many promised benefits but also increased risks of certain illnesses.
The biggest shock came that summer when a major arm of the Women’s Health Initiative (WHI) was halted after women on HRT showed higher risks of breast cancer, stroke, and heart disease. What was thought to protect the heart appeared to do the opposite. Yes, fewer hip fractures and lower colon cancer rates were seen, but overall risks outweighed the possible gains.
Two decades later, science sees this very differently. The early conclusions were misread and applied to the wrong group. WHI participants averaged 63 years of age, many more than 10 years past menopause, already carrying age-related vascular changes. The study also used equine estrogen from pregnant mares and synthetic progestin - both now known to have stronger cardiovascular impacts than today’s estradiol and micronized progesterone.
Take it or not?
The “Timing Hypothesis” is now widely accepted: Starting HRT within 10 years of menopause or before 60 offers net cardiovascular benefits and lowers overall mortality.
HRT can be safe and effective when begun at the right time using transdermal estrogen and micronized progesterone.
Yet, HRT remains a mixed bag. Consult your doctor, undergo personalised assessment, understand risks, tailor your plan, monitor regularly, and consider alternatives like resistance training and cardio - especially if osteoporosis and heart health are your primary concerns.
Zareer Patell
#HRT #HormoneHealth #MenopauseCare #WomenHealth #BioIdenticalHormones #HeartHealth #OsteoporosisPrevention #HealthyAging #ScienceBasedHealth
Comments